Santa Ana, CA, United States of America

John A Hooper

This inventor holds 1 USPTO granted patent. Top assignee: Baxter Travenol Laboratories, Inc.. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John A Hooper. Retrieved from https://idiyas.com/inventor/john-a-hooper-wxf8tss3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John A. Hooper: Innovator in Gamma Globulin Concentrates

Introduction

John A. Hooper is a notable inventor based in Santa Ana, CA (US). He has made significant contributions to the field of medical science, particularly in the development of gamma globulin concentrates. His innovative work has the potential to improve patient care and treatment outcomes.

Latest Patents

John A. Hooper holds a patent for a "Stabilized gamma globulin concentrate." This invention addresses the stabilization of gamma globulin concentrates against anticomplement activity generation during lyophilization. The patent emphasizes the inclusion of a physiologically acceptable, substantially nonsurface-active hydrophilic macromolecule in the concentrate. This advancement allows for the safe administration of improved concentrates to patients.

Career Highlights

Hooper is associated with Baxter Travenol Laboratories, Inc., where he has contributed to various research and development projects. His work focuses on enhancing the safety and efficacy of medical treatments through innovative solutions.

Collaborations

Some of his notable coworkers include Samia Mankarious and Catherine R. Liu-Rash. Their collaborative efforts have likely contributed to the advancements in the field of gamma globulin concentrates.

Conclusion

John A. Hooper's contributions to the field of gamma globulin concentrates exemplify the impact of innovation in medical science. His patent reflects a commitment to improving patient safety and treatment efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…